How to select healthy sperm for intracytoplasmic sperm injection in samples with high sperm DNA fragmentation?
Autors de IIS La Fe
Autors aliens a IIS La Fe
- Gul, Murat
- Jindal, Sunil
- Vogiatzi, Paraskevi
- Saleh, Ramadan
- Durairajanayagam, Damayanthi
- Parmegiani, Lodovico
- Boitrelle, Florence
- Colpi, Giovanni M
- Agarwal, Ashok
Grups d'Investigació
Abstract
The body of evidence supports the negative impact of increased sperm DNA fragmentation (SDF) on natural fertility as well as assisted reproduction conditions. High SDF has been correlated with low pregnancy and delivery rates following intrauterine insemination. Also, high SDF is accused of reducing the rates of fertilization, implantation, pregnancy, and live birth following in-vitro fertilization (IVF). Despite no impact of high SDF on fertilization or pregnancy rates following intracytoplasmic sperm injection (ICSI), it has been correlated with poor embryo quality and a higher risk of miscarriage. Several methods have been introduced to help select sperm with the best DNA quality to be used in assisted reproductive technology procedures. These include magnetic-activated cell sorting, intracytoplasmic morphologically selected sperm injection, physiologic ICSI, and microfluidic sperm sorters, among others. This article aimed to discuss the impact of high SDF in infertile men on the reproductive outcome of couples undergoing IVF/ICSI. Additionally, this review highlights the principles, advantages, and limitations of different techniques that are currently used for the selection of sperm with intact DNA to be utilized for ICSI.
Dades de la publicació
- ISSN/ISSNe:
- 0031-0808, 1827-1898
- Tipus:
- Article
- Pàgines:
- 148-158
- PubMed:
- 37194246
- Factor d'Impacte:
- 0,446 SCImago ℠
- Quartil:
- Q3 SCImago ℠
Panminerva medica Edizioni Minerva Medica
Cites Rebudes en Web of Science: 2
Documents
- No hi ha documents
Filiacions
Keywords
- Sperm injections; intracytoplasmic; Infertility; male; DNA fragmentation
Projectes associats
Evalución del tratamiento clínico en varones con oligospermia severa, fallos de ICSI y elevada fragmentación de ADN mediante el uso de espermatozoides testiculares.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
PI18/00325 . INSTITUTO DE SALUD CARLOS III . 2019
Contrato PFIS: Predoctorales de formación en investigación en salud.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
FI19/00051 . INSTITUTO DE SALUD CARLOS III . 2020
Influencia del virus del papiloma humano (VPH) en semen sobre los resultados reproductivos y lavado de semen con heparinasa como opción terapéutica en la infección.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
PI21/00322 . INSTITUTO DE SALUD CARLOS III . 2022
Influencia del virus del papiloma humano (VPH) en semen sobre los resultados reproductivos y lavado de semen con heparinasa como opción terapéutica en la infección.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
CIACIF/2021/016 . CONSELLERIA DE INNOVACIÓN, UNIVERSIDADES, CIENCIA Y SOCIEDAD DIGITAL . 2022
Identificación de biomarcadores de receptividad endometrial mediante lipidómica para mejorar los tratamientos de reproducción asistida.
Investigador Principal: NICOLÁS GARRIDO PUCHALT
FPU21/00988 . MINISTERIO DE UNIVERSIDADES . 2022